Deutsche Bank Downgrades Gap to Hold, Lowers Price Target to $9
Deutsche Bank analyst Gabriella Carbone downgrades Gap (NYSE:GPS) from Buy to Hold and lowers the price target from $12 to $9.
B of A Securities Downgrades Sherwin-Williams to Neutral, Lowers Price Target to $292
B of A Securities analyst Steve Byrne downgrades Sherwin-Williams (NYSE:SHW) from Buy to Neutral and lowers the price target from $313 to $292.
B of A Securities Downgrades Veritone to Neutral, Lowers Price Target to $10
B of A Securities analyst Koji Ikeda downgrades Veritone (NASDAQ:VERI) from Buy to Neutral and lowers the price target from $14 to $10.
Baird Downgrades Verra Mobility to Neutral
Baird analyst David Koning downgrades Verra Mobility (NASDAQ:VRRM) from Outperform to Neutral.
Stifel Downgrades Atara Biotherapeutics to Hold, Lowers Price Target to $5
Stifel analyst Benjamin Burnett downgrades Atara Biotherapeutics (NASDAQ:ATRA) from Buy to Hold and lowers the price target from $16 to $5.
Goldman Sachs Downgrades Clearwater Analytics Hldg to Sell, Lowers Price Target to $12
Goldman Sachs analyst Gabriela Borges downgrades Clearwater Analytics Hldg (NYSE:CWAN) from Neutral to Sell and lowers the price target from $23 to $12.
Cantor Fitzgerald Downgrades Humanigen to Neutral, Lowers Price Target to $2
Cantor Fitzgerald analyst Louise Chen downgrades Humanigen (NASDAQ:HGEN) from Overweight to Neutral and lowers the price target from $30 to $2.
HC Wainwright & Co. Downgrades Humanigen to Neutral
HC Wainwright & Co. analyst Joseph Pantginis downgrades Humanigen (NASDAQ:HGEN) from Buy to Neutral.
Goldman Sachs Downgrades Harmony Biosciences to Neutral, Announces $55 Price Target
Goldman Sachs analyst Corinne Jenkins downgrades Harmony Biosciences (NASDAQ:HRMY) from Buy to Neutral and announces $55 price target.
RBC Capital Downgrades GrafTech International to Sector Perform, Lowers Price Target to $7
RBC Capital analyst Arun Viswanathan downgrades GrafTech International (NYSE:EAF) from Outperform to Sector Perform and lowers the price target from $10 to $7.